Established Global Presence Gleamer has integrated its AI solutions into over 2,000 medical institutions worldwide, indicating a strong existing customer base and international validation that can facilitate cross-selling and expansion into new markets.

Strategic Acquisitions Recent acquisitions of Caerusmedical and Pixyl enhance Gleamer’s capabilities in neural and lumbar MRI diagnostics, creating opportunities to upsell specialized AI tools to existing clients and target healthcare providers with advanced imaging needs.

Growing Revenue & Funding With a revenue estimate of up to 10 million dollars and recent funding of 8.7 million euros, Gleamer has financial resources and proven market traction that support scaling sales efforts and developing new solutions for diverse radiology applications.

Partnership Network Collaborations with industry leaders like Ferrum Health, TeraRecon, and Aidoc demonstrate Gleamer's positioning as a preferred AI partner, opening avenues to expand sales through channel partnerships and integrated platform offerings.

Award-Winning Innovation Recognition such as the Eurominnies Best New Radiology Vendor award and scientific accolades associate Gleamer with innovation and excellence, which can be leveraged to build credibility and attract new hospital and imaging center clients.